Abstract
Nitric oxide (NO) is a versatile cellular messenger performing a variety of physiologic and pathologic actions in most tissues. It is particularly important in the nervous system, where it is involved in multiple functions, as well as in neuropathology, when produced in excess. Several of these functions are based on interactions between NO produced by neurons and NO produced by glial cells, mainly astrocytes and microglia. The present paper briefly reviews some of these interactions, in particular those involved in metabolic regulation, control of cerebral blood flow, axonogenesis, synaptic function and neurogenesis. Aim of the paper is mainly to underline the physiologic aspects of these interactions rather than the pathologic ones.
Keywords: Nitric oxide, Nitric oxide synthases, Neurons, Astrocytes, Microglia
Current Neuropharmacology
Title:Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes
Volume: 10 Issue: 4
Author(s): Antonio Contestabile, Barbara Monti and Elisabetta Polazzi
Affiliation:
Keywords: Nitric oxide, Nitric oxide synthases, Neurons, Astrocytes, Microglia
Abstract: Nitric oxide (NO) is a versatile cellular messenger performing a variety of physiologic and pathologic actions in most tissues. It is particularly important in the nervous system, where it is involved in multiple functions, as well as in neuropathology, when produced in excess. Several of these functions are based on interactions between NO produced by neurons and NO produced by glial cells, mainly astrocytes and microglia. The present paper briefly reviews some of these interactions, in particular those involved in metabolic regulation, control of cerebral blood flow, axonogenesis, synaptic function and neurogenesis. Aim of the paper is mainly to underline the physiologic aspects of these interactions rather than the pathologic ones.
Export Options
About this article
Cite this article as:
Contestabile Antonio, Monti Barbara and Polazzi Elisabetta, Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes, Current Neuropharmacology 2012; 10 (4) . https://dx.doi.org/10.2174/1570159X11209040303
DOI https://dx.doi.org/10.2174/1570159X11209040303 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Optical Sensors for Detection of Amino Acids
Current Medicinal Chemistry The Antidiabetic PPARγ Ligands: An Update on Compounds in Development
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Cerebrovascular Damage as a Cause for Alzheimers Disease
Current Neurovascular Research Cyclodextrin-Based Delivery Systems for Arthritic Diseases: From Development to Experimental Therapeutics
Current Pharmaceutical Design Regulation of Apoptosis by SYB in HepG2 Liver Cancer Cells is Mediated by the P53/Caspase 9 Axis
Anti-Cancer Agents in Medicinal Chemistry Transcription Factors as Therapeutic Targets in CNS Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Aquaporin and Vascular Diseases
Current Neuropharmacology Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
CNS & Neurological Disorders - Drug Targets Progress in the Rational Design for Polypharmacology Drug
Current Pharmaceutical Design The Function and Regulation of BMP6 in Various Kinds of Stem Cells
Current Pharmaceutical Design Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency
Current Drug Targets Nanoparticle-Based Gene Therapy Intervention for Stroke Treatment: A Systematic Review
Current Gene Therapy Melatonin Decreases Levels of S100β and NFκB, Increases Levels of Synaptophysinina Rat Model of Alzheimer's Disease
Current Aging Science Melatonin Attenuates Methamphetamine-Induced Neurotoxicity
Current Pharmaceutical Design Mitochondria-Targeted Drugs
Current Molecular Pharmacology Medical Management of Parkinsons Disease: Focus on Neuroprotection
Current Neuropharmacology Diagnostic Biomarkers of Epilepsy
Current Pharmaceutical Biotechnology Establishment of Cholinergic Neuron-like Cell Lines with Differential Vulnerability to Nitrosative Stress
Current Neurovascular Research Albumin Infusion Therapy in Stroke, Sepsis and the Critically Ill
Current Nutrition & Food Science